Schizophrenia clinical trials - what they tell us?
Friday 27th May 2022, 2 PM (Central European Summer Time) Duratin 120 minutes
Clinical trials are the cornerstone of current evidence-based medicine. Designs range from effectiveness trials with maximized internal validity but limited external generalizability, to effectiveness and large simple trials that maximize external validity but have reduced precision. Data analytics have equally evolved and become very sophisticated, and it has become increasingly important to choose the most appropriate statistical analysis plan for a given trial design, research question and atiempt at minimizing type I and/or type II error. Trial design, conduct and interpretation are critical components that need to be focused on. Both failed and successful trials provide an opportunity for learning.
Our Faculties are:
Prof. hc mult. Hans-Jürgen Möller, Past President of the Collegium Internationale Neuro-Psychopharmacologicum (CINP), Department of Psychiatry, Ludwig Maximilians University, Munich, Germany
Prof C.U. Correll, Professor of Psychiatry and Molecular Medicine, The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY USA Professor of Child and Adolescent Psychiatry, Charité University Medicine, Berlin, Germany
Friday 27th May 2022, 2 PM Central European Summer Time
02:00 pm – 02:07 pm: Welcome address - Prof Afzal Javed, President World Psychiatric Association
02:07 pm – 02:15 pm: Introduction of Speakers – Prof Peter Morozov
02:15 pm – 03:00 pm: Prof Hans-Jürgen Möller Clinical trial designs and data interpretation
03:00 pm – 03:45 pm: Prof C.U. Correll What do successful trials tell us and what are key learning points from failed clinicaltrials?
03:45 pm – 04:00 pm: Question and Answer
For all Enquiries please email email@example.com
Free access to the webinar. For Registration, please click here: Proceed for Registration
Participants can receive a CPD Certificate on complimentary basis (on request) after attending the Webinar.
This meeting has been supported by a financial grant, for educational purposes, from Gedeon Richter Plc and Recordati S.P.A. No influence has been exerted on the Agenda or its materials.